Small-molecule screening using a human primary cell model of HIV latency identifies compounds that reverse latency without cellular activation.
Yang HC, Xing S, Shan L, O'Connell K, Dinoso J, Shen A, Zhou Y, Shrum CK, Han Y, Liu JO, Zhang H, Margolick JB, Siliciano RF.
J Clin Invest. 2009 Nov;119(11):3473-86. doi: 10.1172/JCI39199. Epub 2009 Oct 1.PMID: 19805909 [PubMed - indexed for MEDLINE]Related articlesFree article